Approximately half of the top 20 terms were related to Nobel Prize or Clarivate Citation Laureates, and the top terms of the indicators were more likely to appear in Wikipedia than terms extracted ...

Clarivate PLC (NYSE:CLVT), a global leader in providing trusted insights and analytics with a market capitalization of $2.79 billion, is currently navigating through a period of significant ...

Anne Lecocq, SVP and GM, R&D, Life Sciences & Healthcare, Clarivate, said: "The ability to assess the safety of drug targets early in development is a critical factor in reducing costly late-stage ...

François Neuville, Senior Vice President, Brand IP, Clarivate, said: "Trademark professionals are under pressure to make critical decisions when creating and protecting brands. Beyond the ...

LONDON, May 15, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released the Trademark filing trends 2025 report, analyzing ten key ...

On May 19, Clarivate Plc (NYSE:CLVT) launched RiskMark, an AI-driven trademark risk evaluation tool combining CompuMark trademark data and Darts-ip litigation records. Using 172.5 million ...

Explore Clarivate stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CLVT. It's widely believed that insiders know how well a company is operating.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

First Impact Factors for New Fully Open Access Journals IEEE also announced that two more of IEEE’s recently launched fully open access journals were accepted for indexing by Clarivate and received ...

It offers better efficacy than orally administered carbidopa-levodopa, dosing flexibility and a more convenient pump than existing and upcoming competitors; 6) Lecanemab: Clarivate delivers a vote ...